DCF — PENOBSCOT BAY MEDICAL CENTER
Enterprise Value: $-151.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-151.8M
Enterprise Value
$-50.8M
PV of Cash Flows
$-101.0M
PV of Terminal Value
$-162.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $176.8M | $-8.0M | -4.0% | $-15.4M | $-14.0M |
| Year 2 | $182.1M | $-6.4M | -3.0% | $-14.1M | $-11.6M |
| Year 3 | $187.5M | $-4.7M | -2.0% | $-12.6M | $-9.5M |
| Year 4 | $193.2M | $-3.9M | -2.0% | $-12.0M | $-8.2M |
| Year 5 | $199.0M | $-3.5M | -2.0% | $-11.9M | $-7.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-151.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$171.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999825200521
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5